Showing results (1-10 of 273) with videos related to
Sort By:
Pageof 28
Therapeutic Advances in Neurological Disorders|April 5, 2019
Pulsed immune reconstitution therapy in multiple sclerosisPer Soelberg Sorensen, Finn SellebjergCNS Drugs|January 30, 2020
Anti-CD20 Monoclonal Antibodies for Relapsing and Progressive Multiple SclerosisFinn Sellebjerg, Morten Blinkenberg, Per Soelberg SorensenExpert Review of Neurotherapeutics|December 7, 2023
An update on combination therapies for multiple sclerosis: where are we now?Per Soelberg Sorensen, Melinda Magyari, Finn SellebjergMultiple Sclerosis and Related Disorders|February 12, 2021
Age and sex as determinants of treatment decisions in patients with relapsing-remitting MSPer Soelberg Sorensen, Tine Iskov Kopp, Hanna Joensen, et al.Journal of Neurology|April 15, 2014
Recurrence or rebound of clinical relapses after discontinuation of natalizumab therapy in highly active MS patientsPer Soelberg Sorensen, Nils Koch-Henriksen, Thor Petersen, et al.Brain : a Journal of Neurology|July 26, 2020
The apparently milder course of multiple sclerosis: changes in the diagnostic criteria, therapy and natural historyPer Soelberg Sorensen, Finn Sellebjerg, Hans-Peter Hartung, et al.Current Opinion in Neurology|April 25, 2014
New management algorithms in multiple sclerosisPer Soelberg SorensenJournal of the Neurological Sciences|March 17, 2007
The gap between effect of drugs and effectiveness of treatmentsPer Soelberg SorensenJournal of the Neurological Sciences|February 1, 2003
The role of intravenous immunoglobulin in the treatment of multiple sclerosisPer Soelberg SorensenNeuro-Degenerative Diseases|December 14, 2007
Intravenous polyclonal human immunoglobulins in multiple sclerosisPer Soelberg SorensenPageof 28